ClinicalTrials.Veeva

Menu

Retinal Imaging Using NOTAL-OCT V2.5

Notal Vision logo

Notal Vision

Status

Completed

Conditions

AMD

Treatments

Device: NOTAL OCT V2.5

Study type

Observational

Funder types

Industry

Identifiers

NCT03600519
BNZ-0060-18

Details and patient eligibility

About

Primary objectives:

To compare between retinal measurements, done by the NOTAL-OCT V2.5 device and a commercial OCT.

Secondary objectives:

  1. To evaluate the level of agreement between the NOTAL-OCT V2.5 and a commercial OCT in the presence of fluid as identified in the OCT images, in the central 10 degrees of the macula.
  2. To evaluate the repeatability of the NOTAL-OCT V2.5

Full description

Study population:

  1. AMD population - intermediate and advanced AMD (with active and nonactive CNV)
  2. DR population. Patient with and without DME

Enrollment

87 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  1. Inclusion Criteria:

    a- Ability and agreement to give informed consent (IC) b -Diagnosis of AMD or DR in SE by OCT c- Ability to undergo OCT scans d- VA of 20/400 (6/120) or better in SE

  2. Exclusion Criteria:

    1. AMD and DR in the same SE
    2. Evidence of macular disease other than AMD or DME in SE
    3. Patient with dilated eye(s)

Trial design

87 participants in 1 patient group

AMD Patients
Description:
OCT scan
Treatment:
Device: NOTAL OCT V2.5

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems